CN106906238A - A kind of streptomycete antibiotic biological synthesis gene cluster multicopy amplification method and application - Google Patents

A kind of streptomycete antibiotic biological synthesis gene cluster multicopy amplification method and application Download PDF

Info

Publication number
CN106906238A
CN106906238A CN201510971596.4A CN201510971596A CN106906238A CN 106906238 A CN106906238 A CN 106906238A CN 201510971596 A CN201510971596 A CN 201510971596A CN 106906238 A CN106906238 A CN 106906238A
Authority
CN
China
Prior art keywords
gene
gene cluster
streptomyces
cluster
streptomycete
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201510971596.4A
Other languages
Chinese (zh)
Other versions
CN106906238B (en
Inventor
芦银华
李雷
郑国松
阮丽军
戈梅
姜卫红
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Health Creation Center for Biopharmaceutical R&D Co.,Ltd.
Center for Excellence in Molecular Plant Sciences of CAS
Original Assignee
Shanghai Health Creation Center For Biopharmaceutical R&d Co ltd
Shanghai Institutes for Biological Sciences SIBS of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Health Creation Center For Biopharmaceutical R&d Co ltd, Shanghai Institutes for Biological Sciences SIBS of CAS filed Critical Shanghai Health Creation Center For Biopharmaceutical R&d Co ltd
Priority to CN201510971596.4A priority Critical patent/CN106906238B/en
Publication of CN106906238A publication Critical patent/CN106906238A/en
Application granted granted Critical
Publication of CN106906238B publication Critical patent/CN106906238B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/10Plasmid DNA
    • C12N2800/101Plasmid DNA for bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465Streptomyces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465Streptomyces
    • C12R2001/55Streptomyces hygroscopicus

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The present invention relates to a kind of streptomycete antibiotic biological synthesis gene cluster multicopy amplification method and application.The present invention is while some uncorrelated gene clusters are deleted, introducing multiple attB sites, by site-specific recombination system, once realizes that target gene cluster multicopy is expanded, and greatly improves target product yield.The method of the present invention is not only simple to operate effective, and the genetic stability of engineering bacteria is good.

Description

A kind of streptomycete antibiotic biological synthesis gene cluster multicopy amplification method and application
Technical field
The invention belongs to metabolic engineering field, more particularly it relates to a kind of streptomycete antibiotic biosynthesis base Because of cluster multicopy amplification method and application.
Background technology
Microorganism produce the natural products (also known as secondary metabolite) with bioactivity, be the mankind resistance cancer, The treasure of aging and infectious diseases etc..By taking antibiotic as an example, according to statistics, in the antibiotic of the natural origin reported In, having 50% or so is produced by the streptomycete of Actinomy cetaceae.Antibiotic biological synthesis gene cluster contain structure, resistance, The gene such as outer row, regulation and control and rear modification, gene cluster size is general in 20-150kb.Along with the rapid hair of metabolic engineering Exhibition, improved by designing antibiotic yield strategy be developed with application, including Optimum Regulation network, reduce competition approach, carry Height endurability, increase precursor supply etc..These strategies avoid required substantial amounts of time and human cost when classic mutagenesis are screened, The biosynthesis of secondary metabolite can effectively be optimized.
Streptomyces, in the Streptomycetaceae of Actinomycetal, is a kind of prokaryotes, and it is the Typical Representative of actinomyces, is belonged to Aerobic bacteria.It is distributed widely in that water content is relatively low, ventilation is good, in the abundant and subalkaline soil of organic matter, in fresh water, seawater And be also distributed in mud.
Rotation streptomycete (Streptomyces pristinaespiralis) be it is a kind of under suitable condition, Ke Yisheng Produce the streptomycete of pyostacin (Pristinamycin).
Although streptomycete has more been applied to produce antibiotic now, in view of its metabolic mechanism is complicated, production During uncertain factor it is more, this area still need further exploitation optimize its biosynthesis antibiotic metabolism on the way The technology of footpath, Optimum Regulation network etc., to further improve the yield of its biosynthesis antibiotic.
The content of the invention
It is an object of the invention to provide a kind of streptomycete antibiotic biological synthesis gene cluster multicopy amplification method and should With.
In the first aspect of the present invention, there is provided one kind makes to be integrated into multicopy target gene or target in streptomyces gene group The method of gene cluster, methods described includes:
(1) the attB sites of at least one external source are introduced in streptomyces gene group, acquisition carries external source attB sites Streptomycete;
(2) method by engaging transfer, target gene or target gene cluster are incorporated into the streptomycete of step (1), Selection target gene or target gene cluster are incorporated into the strepto- in the endogenous attB sites of streptomyces gene group and external source attB sites Bacterium, so as to obtain the streptomycete for being integrated into multi-copy gene or gene cluster.
In a preference, the attB sites of described at least one external source are the 1-2 attB site of external source;Preferably Ground is 2 attB sites of external source.
In another preference, the attB sites of 1-2 described external source are incorporated into streptomyces gene group selected from following 1-2 position:
I types polyketone biological synthesis gene cluster (Biosynthetic gene cluster 1, BGC1) in streptomyces gene group Position, and replace the former I types polyketone biological synthesis gene cluster of the position;It is preferred that corresponding to rotation streptomycete genome Sequence (GenBank accession number:NZ_ABJI00000000.2), described I type polyketone biological synthesis gene cluster is located at the The site of 4050261-4072243.
Non-ribosomal peptides biological synthesis gene cluster in streptomyces gene group (Biosynthetic gene cluster 2, BGC2) position, and replace the former non-ribosomal peptides biological synthesis gene cluster of the position;It is preferred that corresponding to the rotation strepto- that begins Bacterium genome sequence (GenBank accession number:NZ_ABJI00000000.2), described non-ribosomal peptides biological synthesis gene cluster Positioned at the site of 1106415-1130923;Or
Type III polyketone biological synthesis gene cluster in streptomyces gene group (Biosynthetic gene cluster 3, BGC3) position, and replace the former type III polyketone biological synthesis gene cluster of the position;It is preferred that corresponding to rotation streptomycete Genome sequence (GenBank accession number:NZ_ABJI00000000.2), described non-ribosomal peptides biological synthesis gene cluster position In the site of 686202-696578.
In another preference, described streptomycete includes but is not limited to:Rotation streptomycete, streptomyces coelicolor, rose Rare spore streptomycete or streptomyces hygroscopicus.
In another preference, described streptomycete is missing from papR5 genes and comprising papR4 and papR6 genes.
In another preference, there is 1 endogenous attB site in the genome of described streptomycete.
In another preference, described target gene or target gene cluster is included but is not limited to:Pyostacin component II (PII) synthetic gene cluster, pyostacin I (PI) synthetic gene cluster, Daptomycin synthetic gene cluster or rapamycin synthesis base Because of cluster.
In another preference, in step (2), target gene or target gene cluster are introduced by the method for engaging transfer Include to the method in the streptomycete of step (1):By the plasmid of foreign gene-carrying or gene cluster to engage transfer in the way of lead Enter in the streptomycete of step (1).
In another aspect of this invention, there is provided a kind of streptomyces gene engineering bacteria, wrapped in the genome of the genetic engineering bacterium Include the attB sites of at least one external source, 1 endogenous endogenous attB site.
In a preference, the attB sites of described at least one external source are the 1-2 attB site of external source;Preferably Ground is 2 attB sites of external source.
In another preference, the attB sites of 1-2 described external source are incorporated into streptomyces gene group selected from following 1-2 position:
I types polyketone biological synthesis gene cluster (Biosynthetic gene cluster 1, BGC1) in streptomyces gene group Position, and replace the former I types polyketone biological synthesis gene cluster of the position;
Non-ribosomal peptides biological synthesis gene cluster in streptomyces gene group (Biosynthetic gene cluster 2, BGC2) position, and replace the former non-ribosomal peptides biological synthesis gene cluster of the position.
Type III polyketone biological synthesis gene cluster in streptomyces gene group (Biosynthetic gene cluster 3, BGC3) position, and replace the former type III polyketone biological synthesis gene cluster of the position.(it is preferred that corresponding to the rotation strepto- that begins Bacterium genome sequence (GenBank accession number:NZ_ABJI00000000.2), described non-ribosomal peptides biological synthesis gene cluster Positioned at the site of 686202-696578.)
In another aspect of this invention, there is provided the purposes of described streptomyces gene engineering bacteria, for preparing, carrying to be copied The streptomyces gene engineering bacteria of shellfish foreign gene or gene cluster.
In another preference, described multicopy foreign gene or gene cluster is 2-3 copies.
In another aspect of this invention, there is provided multicopy target gene or target gene cluster are integrated with a kind of genome Streptomyces gene engineering bacteria, includes up to 3 target gene clusters of copy in the genome of the genetic engineering bacterium, and positioned at following In position as many as 3 positions:
Endogenous attB sites position in streptomyces gene group, and replace the original attB sites in the position;It is preferred that Corresponding to rotation streptomycete genome sequence (GenBank accession number:NZ_ABJI00000000.2), described endogenous attB Point is located at the site of 4303498-4303477.
I types polyketone biological synthesis gene cluster (Biosynthetic gene cluster 1, BGC1) in streptomyces gene group Position, and replace the former I types polyketone biological synthesis gene cluster of the position;Or
Non-ribosomal peptides biological synthesis gene cluster in streptomyces gene group (Biosynthetic gene cluster 2, BGC2) position, and replace the former non-ribosomal peptides biological synthesis gene cluster of the position;Or
Type III polyketone biological synthesis gene cluster in streptomyces gene group (Biosynthetic gene cluster 3, BGC3) position, and replace the former type III polyketone biological synthesis gene cluster of the position.
In another preference, described target gene or target gene cluster is included but is not limited to:Pyostacin component II (PII) synthetic gene cluster, pyostacin I (PI) synthetic gene cluster, Daptomycin synthetic gene cluster or rapamycin synthesis base Because of cluster etc..
In a preference, there is provided a kind of method of utilization streptomycete high efficient expression target gene or target gene cluster, Described method includes:
A () prepares streptomycete in described method, make to be integrated into multicopy target gene or target in streptomyces gene group Gene cluster;
B streptomycete that () incubation step (a) is obtained, so that high efficient expression target gene or target gene cluster.
In another preference, in step (b), also macroporous absorbent resin is added in the nutrient solution of streptomycete;It is preferred that Add 1-12% (w/v);The more preferably macroporous absorbent resin of 3-8%.
Other side of the invention, due to this disclosure, is to those skilled in the art apparent 's.
Brief description of the drawings
Fig. 1, the tactful schematic diagram of gene cluster multicopy amplification.Using CRISPR Cas9 systems knock out other non-targeted bases During because of cluster, direct in-situ introduces an attB site;BAC-F1F15 (is contained into PII synthetic genes by engaging branch mode Cluster) import in improved bacterial strain, can respectively obtain the engineering bacteria for increasing one, two or three copy.
The efficiency comparative that Fig. 2, difference PII synthetic genes cluster copy number are introduced.
(A) while introducing two efficiency of copy of PII synthetic genes cluster.
(B) while introducing three efficiency of copy of PII synthetic genes cluster.M representation DNAs marker, C represent control strain Δ papR5+R4R6 (is named as SBJ1000).
PII (the Pristinamycin II of the engineering bacteria that Fig. 3, difference PII synthetic gene clusters copy number are obtained after introducingA) Yield comparison.
Fig. 4, engineering bacteria SBJ1003 (comprising the three PII synthetic genes clusters copy being exogenously introduced) are in the macropore of addition 6% PII yield after polymeric adsorbent HB60.
Specific embodiment
It is more clean in order to obtain in the related biosynthesis research process of target gene cluster is carried out using streptomycete Metabolism spectrum, the present inventor deletes some and the incoherent gene cluster of target gene cluster in streptomycete, is found during being somebody's turn to do, and deletes While some non-targeted gene clusters, attB sites directly are re-introduced into corresponding position, by carrying out engagement transfer, be capable of achieving The disposable multicopy insertion of external source target gene cluster, the related biosynthesis of further optimization aim gene cluster.
As used herein, term " locus specificity restructuring " is that a class depends on the homologous heavy of small range homologous sequence joint conference Prescription formula, it is necessary to by the participation of integrase (such as phiC31) and specific recombination site (such as attB/attP), most external source at last In plasmid integration to genome.
As used herein, term " introducing " or " conversion " refers to that exogenous polynucleotide is transferred into the host cell (present invention In be streptomycete).Alternatively, exogenous polynucleotide can be integrated into host genome.
As used herein, " external source " or " heterologous " gene or albumen refer to not to be naturally contained in primary object (this It is streptomycete in invention) gene or albumen in genome.
The invention provides a kind of side for making to be integrated into multicopy target gene or target gene cluster in streptomyces gene group Method, methods described includes:(1) the attB sites of at least one external source are introduced in streptomyces gene group, acquisition carries external source The streptomycete in attB sites;(2) method by engaging transfer, step (1) is incorporated into by target gene or target gene cluster Streptomycete in, selection target gene or target gene cluster are incorporated into the endogenous attB sites of streptomyces gene group and external source attB The streptomycete in site, so as to obtain the streptomycete for being integrated into multi-copy gene or gene cluster.
The attB sites of at least one external source are introduced in streptomyces gene group, 2 the attB of external source is preferably introduced Point.There is 1 attB site due to generally endogenous in streptomyces gene group, so as at least 2 external source targets of copy can be introduced Gene or target gene cluster;Preferably introduce 3 the external source target genes or target gene cluster of copy.
The present inventor has found that the copy number of introducing is not The more the better under study for action, outside being introduced using 4 attB sites When source target gene or target gene cluster, cause thalline dead because integrase occurs cutting in many places, mesh is obtained after introducing Bacterial strain efficiency it is not high.
There is 1 attP site on plasmid containing target gene or gene cluster, after transfer is engaged, it is common with attB Effect, so as to can realize that foreign gene or the fixed point of foreign gene cluster are introduced.
As preferred embodiment of the invention, while attB sites are introduced, also deleted and target on specific position Incoherent other gene clusters of biosynthesis of gene or target gene cluster, so as to reduce precursor competition, obtain more clean Metabolism spectrum.
Deleting specific gene cluster and introduce attB gene clusters can be using some technology well known in the art, as this The preferred embodiment of invention, is sieved using CRISPR/Cas9 systems and subtracts incoherent gene cluster.At present, in the prior art, had Some are used for the plasmid for realizing carrying out streptomyces gene editor based on CRISPR/Cas9 principles, such as pKCcas9dO.
Used as preferred embodiment of the invention, described streptomycete is rotation streptomycete, introduces 1-2 the attB of external source Point, and be incorporated into streptomyces gene group selected from 1-2 following position:
4050261-4072243 sites in streptomyces gene group, and replace the former I types polyketone biosynthesis gene of the position Cluster (BGC1);Or
1106415-1130923 sites in streptomyces gene group, and replace the former non-ribosomal peptides biosynthesis of the position Gene cluster (BGC2);Or
The site of 686202-696578 in streptomyces gene group, and replace the biological conjunction of former type III polyketone of the position Into gene cluster (BGC3).
It is further preferable that described rotation streptomycete is missing from papR5 genes and simultaneously overexpression papR4 and papR6 bases The streptomycete of cause.Missing papR5 or overexpression papR4 and papR6 can effectively improve PII yield, and obtain regulated and control network More lax chassis bacterium.
Used as preferred embodiment of the invention, described target gene or target gene cluster is:Pyostacin component II (PII) Synthetic gene cluster.In order that PII can efficiently be expressed, introduce external source attB while, the present inventor also delete with Pyostacin synthesis it is incoherent, gene cluster synthesize secondary metabolite when with pyostacin synthesis compete acetyl coenzyme A, third The gene cluster of two acyl coenzyme A or amino acid precursor.
Present invention also offers streptomyces gene engineering bacteria prepared by application preceding method, the genome of the genetic engineering bacterium Include the attB sites of at least one external source, 1 endogenous endogenous attB site.It is preferred that described is at least outer containing 1 The attB sites in source;The preferably 2 attB sites of external source.More preferably, the attB sites of 1-2 described external source are incorporated into 1-2 following position is selected from streptomyces gene group:
I types polyketone biological synthesis gene cluster position in streptomyces gene group, and replace the former I types polyketone of the position to give birth to Thing synthetic gene cluster;Or
Non-ribosomal peptides biological synthesis gene cluster position in streptomyces gene group, and replace the former non-ribose of the position Body peptide biological synthesis gene cluster;Or
Type III polyketone biological synthesis gene cluster position in streptomyces gene group, and replace the former type III of the position to gather Ketone biological synthesis gene cluster.
Present invention also offers the streptomycete base that multicopy target gene or target gene cluster are integrated with a kind of genome Because of engineering bacteria, 3 target gene clusters of copy are included up in the genome of the genetic engineering bacterium, and be located at:
Endogenous attB sites position in streptomyces gene group, and replace the original attB sites in the position;
I types polyketone biological synthesis gene cluster position in streptomyces gene group, and replace the former I types polyketone of the position to give birth to Thing synthetic gene cluster;Or
Non-ribosomal peptides biological synthesis gene cluster position in streptomyces gene group, and replace the former non-ribose of the position Body peptide biological synthesis gene cluster;Or
Type III polyketone biological synthesis gene cluster in streptomyces gene group (Biosynthetic gene cluster 3, BGC3) position, and replace the former type III polyketone biological synthesis gene cluster of the position.
In a particular embodiment of the present invention, the present inventor introduces multiple while other non-targeted gene clusters are deleted AttB sites, are expanded with the multicopy for realizing target gene cluster.By taking PII synthetic gene clusters as an example, in rotation streptomycete (Δ PapR5+R4R6 external source imports a PII synthetic gene cluster in), can be by 1.5 times of PII output increaseds.Copied for detection continues increase Whether PII yield can further improve during shellfish number, and the present inventor is deleting other and the pyostacin uncorrelated gene cluster of synthesis While, an attB site is introduced in same position, so as to increased attB numbers in genome, to realize more PII The insertion of synthetic gene cluster copy number.Result finds, two with three copies while the efficiency that introduce be respectively 100% and 10%, it was confirmed that multiple attB sites can utilize locus specificity recombination form effectively to mediate the amplification of target gene cluster.
As preferred embodiment of the invention, after above-mentioned streptomyces gene engineering bacteria is obtained, when fermented and cultured is carried out, Also macroporous absorbent resin is added in the nutrient solution of streptomycete;It is preferred that adding 1-12% (w/v);The more preferably macropore of 3-8% Polymeric adsorbent.
In a particular embodiment of the present invention, with rotation streptomycete (Δ papR5+R4R6) (SBJ1000) for chassis bacterium, point The PII yield of engineering bacteria SBJ1001, SBJ1002 and SBJ1003 that Zeng Jia be after one, two or three copy is respectively reached 468,508 and 720mg/L, yield lifting is notable.By adding macroporous absorbent resin to weaken pyostacin to the anti-of itself Feedback depression effect and the poisonous effect to thalli growth, the PII yield of SBJ1003 reach 1.75g/L, and pole is lifted with respect to chassis bacterium Its is notable.
The method of the gene cluster multicopy amplification of site-specific recombination system mediation of the invention, can be widely used for various The genetic modification of actinomyces, for the fermentation level for improving important microbe natural products has established good basis.
The method of the present invention introduces multiple attB, by locus specificity recombination system while other gene clusters are deleted System, once realizes that target gene cluster multicopy is expanded, and greatly improves target product yield.Due to introduce target gene cluster into from Scattered distribution, the relative gene cluster cascade amplification realized using ZouA-RsA/B systems is not only simple to operate effective, and engineering bacteria Genetic stability more preferably, can be widely used for other industrial actinomyces carries out genetic modification.
Into discrete distribution after being introduced due to target gene cluster, homologous recombination, the chain that the method for the present invention is obtained are not susceptible to The genetic stability of mould genetic engineering bacterium is fine.Therefore, the method for the present invention is established as actinomyces secondary metabolites Output optimization provides a kind of sane, pervasive Reconstruc-tion policy, and site-specific recombination system is utilized when competition approach is weakened The amplification of gene cluster copy number is realized, so as to obtain the superior strain of inheritance stability.
It should be understood that within the scope of the present invention, above-mentioned each technical characteristic of the invention and have in below (eg embodiment) Can be combined with each other between each technical characteristic of body description, so as to constitute new or preferred technical scheme.As space is limited, exist This no longer tires out one by one states.
With reference to specific embodiment, the present invention is expanded on further.It should be understood that these embodiments are merely to illustrate the present invention Rather than limitation the scope of the present invention.The experimental technique of unreceipted actual conditions in the following example, generally according to conventional strip Part such as J. Pehanorm Brookers etc. are write, Molecular Cloning:A Laboratory guide, the third edition, Science Press, the condition described in 2002, or According to the condition proposed by manufacturer.
Bacterial strain, plasmid and reagent that the present invention is used:
(it is named as the present invention relates to rotation streptomycete Streptomyces pristinaespiralis Δs papR5+R4R6 SBJ1000) for laboratory early stage builds, construction method is referring to Li et al., Metabolic Engineering, 2015.
E.coli S17-1 (are shifted) for engaging:Purchased from Biomedal Life Science companies.
HCCB10218 was preserved in China Committee for Culture Collection of Microorganisms's common micro-organisms on November 23rd, 2011 Center (CGMCC), preserving number CGMCC NO.5486.
The plasmid pKCcas9dO arrived used in the present invention, construction method is referring to Huang et al., Acta Biochim Biophys Sin(Shanghai),2015。
The plasmid BAC-F1F15 (containing PII synthetic genes cluster) arrived used in the present invention, wherein containing Escherichia coli Bacterial chromosome (BAC) copied cells, apramycin resistant gene aac (3) IV expression cassettes, phiC31 integrases expression cassette, Integration site attP and oriT (RK2) site related to engagement transfer.Construction method referring to Lei Li et al., Metabolic Engineering,2015。
DNA glue reclaims are purified and plasmid extraction kit is purchased from Axygen companies.
E.Z.N.A.BAC/PAC DNA Kit are purchased from Omega Bio-Tek companies.
KOD plus new are purchased from TOYOBO companies.
Macroporous absorbent resin HB60 is upper extra large MinYong Industrial Co., Ltd.s purchase.
Other conventional reagents are that domestic analysis is pure or import packing.
The culture medium that the present invention is used:
1. LB liquid medium (1L)
Peptone 10g, yeast extract 5g, NaCl 10g, 121 DEG C sterilize 20 minutes.
2. solid LB media (1L)
Peptone 10g, yeast extract 5g, NaCl 10g, agar powder 20g;121 DEG C sterilize 20 minutes.
3. solid RP culture medium prescriptions (1L)
Soluble starch 20g, soybean cake powder 10g, NaCl 2g, KH2PO40.5g, MgSO4.7H2O 1g, CaCO33g, fine jade Cosmetics 20g, adjusts 6.4,121 DEG C of pH to sterilize 20 minutes.
4th, seed culture medium (1L)
Soluble starch 15g, glucose 10g, soybean cake powder 15g, dusty yeast 5g, KNO32.5g, NaCl 2g, CaCO3 4g, adjusts 7.0~7.2,121 DEG C of pH to sterilize 20 minutes.
5th, fermentation medium (1L)
Soluble starch 40g, glucose 22.5g, cotton seed meal 32g, dusty yeast 3.5g, KH2PO40.1g, ZnSO4.7H2O 0.5g, MgSO4.7H2O 0.5g, CaCO36g, adjusts 6.0,121 DEG C of pH to sterilize 20 minutes.
The gene cluster multicopy amplification strategy of embodiment 1, site-specific recombination system mediation
1st, the selection of gene cluster and attB insertion points is deleted
Such as Fig. 1, an attB site is normally only contained in streptomyces gene group, introduce new attB sites and be conducive to introducing The target gene cluster of more multicopy.At the same time, delete and synthesize incoherent other gene clusters with pyostacin, other can be avoided When secondary metabolite synthesizes the precursors such as acetyl coenzyme A, malonyl coenzyme A or amino acid are competed with pyostacin synthesis.
In order to realize deleting uncorrelated gene cluster and introduce the purpose in attB sites, the present inventor by studying point repeatedly Analysis, have chosen 3 non-targeted gene clusters in rotation streptomycete, respectively positioned at rotation streptomycete genome (GenBank accession number: NZ_ABJI00000000.2 4050261-4072243 (BGC1)), 1106415-1130923 (BGC2) and 686202- 696578 (BCG3), may encode a kind of unknown I types polyketone, a kind of non-ribosomal peptides and a kind of type III polyketone respectively.Using CRISPR/Cas9 systems are deleted it and are added attB sites simultaneously one by one.
2nd, it is target gene cluster with PII synthetic genes cluster, builds engineered strain
Using rotation streptomycete SBJ1000 as starting strain, using BGC1, BGC2, BGC3 as non-by what is deleted Target gene cluster, and add attB in corresponding position of deleting.It is target gene cluster with PII biological synthesis gene clusters, builds work Journey bacterial strain.Such as Fig. 1.
As a example by knocking out one attB site of BGC1 and introducing in situ, first using primer BGC1-up-fw/rev, BGC1- Down-fw/rev and BGC1-sgRNA-fw/DM-sgRNA-rev, with HCCB10218 genomes as template, PCR amplifications are obtained respectively The gRNA Expression elements BGC1-sgRNA of upstream and downstream homology arm BGC1-UP, the BGC1-DOWN that must be knocked out and targeting BGC1.Then It is primer to use BGC1-up-fw and DM-sgRNA-rev, and above three PCR primer is template, is expanded with overlapping PCR The mode of increasing obtains BGC1-UP-DOWN-sgRNA, then using Spe I and Hind III digestions, is connected to using identical limitation Property endonuclease digestion carrier pKCcas9dO in, it is final to obtain BGC1 targeting knock out carriers pKCcas9-BGC1-sgRNA.Its In, attB sites have been superimposed upon primer, and in BGC1-down-fw, (italic blackens underscore mark in being shown in Table 1 corresponding primer Sequence).PKCcas9-BGC1-sgRNA engagements are transferred in chassis bacterium SBJ1000, the bacterium colony for growing using ID-BGC1-fw with ID-BGC1-rev enters performing PCR identification and sequencing.The correct bacterial strain of result is cultivated 2-3 generations in non-resistant RP culture mediums and is voluntarily lost Fall plasmid pKCcas9-BGC1-sgRNA, obtain engineering bacteria SBJ1000::attB2.In the bacterial strain, an attB for external source is replaced Original BGC1 (i.e. 4050261-4072243 of rotation streptomycete genome, referring to GenBank step on by genome sequence Record number:NZ_ABJI00000000.2 so that there are 2 attB sites in genome).
The knockout of BGC2 is similar with BGC1, with SBJ1000::AttB2 is the bacterium that sets out, and knockout BGC2 introduces the 3rd attB and obtains Obtain SBJ1000::attB3.Specific method is:First using primer BGC2-up-fw/rev, BGC2-down-fw/rev with BGC2-sgRNA-fw/DM-sgRNA-rev, with HCCB10218 genomes as template, PCR amplifications obtain the upper and lower of knockout respectively The gRNA Expression elements BGC2-sgRNA of trip homology arm BGC2-UP, BGC2-DOWN and targeting BGC2.Then BGC2-up- is used Fw and DM-sgRNA-rev is primer, and above three PCR primer is template, is obtained in the way of overlapping PCR are expanded BGC2-UP-DOWN-sgRNA, then using Spe I and Hind III digestions, is connected to using identical digestion with restriction enzyme Carrier pKCcas9dO in, it is final to obtain BGC2 targeting knock out carriers pKCcas9-BGC2-sgRNA.Wherein, attB sites have been Added in primer to BGC2-down-fw (italic blackens the sequence that underscore is marked in being shown in Table 1 corresponding primer). PKCcas9-BGC2-sgRNA engagements are transferred to chassis bacterium SBJ1000::In attB2, the bacterium colony for growing using ID-BGC2-fw with ID-BGC2-rev enters performing PCR identification and sequencing.The correct bacterial strain of result is cultivated 2-3 generations in non-resistant RP culture mediums and is voluntarily lost Fall plasmid pKCcas9-BGC2-sgRNA, obtain engineering bacteria SBJ1000::attB3.In the bacterial strain, a new external source attB is inserted Enter original BGC2 (i.e. rotation streptomycete genomes 1106415-1130923, referring to GenBank accession number of replacement:NZ_ ABJI00000000.2) so that there are 3 attB sites in genome.
With SBJ1000::AttB3 introduces the 4th attB and obtains SBJ1000 for the bacterium that sets out knocks out BGC3::attB4.Specifically Method is:Primer BGC3-up-fw/rev, BGC3-down-fw/rev and BGC3-sgRNA-fw/DM-sgRNA- are used first Rev, with HCCB10218 genomes as template, PCR amplifications obtain upstream and downstream homology arm BGC3-UP, BGC3- of knockout respectively The gRNA Expression elements BGC3-sgRNA of DOWN and targeting BGC3.Then BGC3-up-fw and DM-sgRNA-rev is used to draw Thing, above three PCR primer is template, obtains BGC3-UP-DOWN-sgRNA in the way of overlapping PCR are expanded, so Afterwards using Spe I and Hind III digestions, it is connected in the carrier pKCcas9dO using identical digestion with restriction enzyme, most BGC3 targeting knock out carriers pKCcas9-BGC3-sgRNA is obtained eventually.Wherein, attB sites have been superimposed upon primer to BGC3- In down-fw (italic blackens the sequence that underscore is marked in being shown in Table 1 corresponding primer).PKCcas9-BGC3-sgRNA engagement transfers To chassis bacterium SBJ1000::In attB3, the bacterium colony for growing is entered performing PCR identification and is surveyed using ID-BGC3-fw and ID-BGC3-rev Sequence.The correct bacterial strain of result cultivates 2-3 generations in non-resistant RP culture mediums and voluntarily loses plasmid pKCcas9-BGC3-sgRNA, obtains Obtain engineering bacteria SBJ1000::attB4.In the bacterial strain, the attB of external source replaces original BGC3 (i.e. rotation streptomycete genes 686202-696578 of group, referring to GenBank accession number:NZ_ABJI00000000.2) so that have 4 in genome Individual attB sites.The primer sequence used in above method is as shown in table 1.
Table 1, list of primers
Note:Roman underscore represents restriction enzyme site, and italic blackens underscore and is labeled as attB sites.
2nd, efficiency comparative when different copy gene clusters are introduced
Using above-mentioned strategy, the present inventor builds obtain engineering bacteria SBJ1000 respectively::attB2、SBJ1000:: AttB3 and SBJ1000::AttB4, contains 2,3 and 4 attB sites respectively in its genome.
By the plasmid (BAC-F1F15) containing PII synthetic gene clusters to engage transfer in the way of imported it is above-mentioned SBJ1000、SBJ1000::AttB2 and SBJ1000::In tri- plants of bacterium of attB3, bacterium colony to be grown enters performing PCR amplification, and pass through Gel electrophoresis is identified.
Result such as Fig. 2, while the efficiency of 2 copies of insertion reaches 100%, the efficiency for inserting 3 copies is only 10%, and 4 PII synthetic genes clusters of insertion do not have bacterium colony to grow when copying.Supposition be when introducing more PII synthetic genes clusters and copying, it is whole Synthase phiC31 (being brought into by BAC-F1F15 plasmids) is cut but can not be repaired in time in genome many places attB sites, from And cause thalline dead.The identification primer of 2 copies of insertion is ID-attB-fw/ID-BGC1-attB-fw and ID-BAC- F1F15-rev, inserts 3 identification primers of copy in addition to above-mentioned two pairs of primers, separately there is ID-BGC2-attB-fw and ID-BAC- F1F15-rev, its sequence is as shown in table 1.
Engineering bacteria PII yield comparisons after embodiment 2, the copy number introducing of difference PII synthetic genes cluster
By above-mentioned strategy, the present inventor is chassis bacterium with SBJ1000, constructs and contains increase PII synthetic genes cluster 1 Individual, 2 or 3 engineering bacterias for copying, are respectively designated as SBJ1001, SBJ1002 and SBJ1003.
The present inventor carries out fermenting experiment to SBJ1001, SBJ1002 and SBJ1003 respectively, with SBJ1000, SBJ1000::attB2、SBJ1000::AttB3 is control.
(1) fermentation process and condition
Rotation streptomycete SBJ1000 and each derivative engineering bacteria line RP flat boards respectively, 30 DEG C of quiescent cultures 3-5 days, The isometric bacterium block of picking accesses seed culture medium respectively, after 27 DEG C of 240rpm cultures 44-48h, is transferred with 8% (v/v) ratio Continue to cultivate into fermentation medium, sampling carries out HPLC measure behind 30,48,72,96 with 120h respectively.
(2) pyostacin assay method
The μ l of nutrient solution 600 are drawn, equal-volume acetone is added, room temperature places 60min after vibration, and 12000 leave heart 5min, take Supernatant, carries out HPLC detections, pillar model:Agilent Eclipse, filler:5 microns of XDB C18, size:4.6mm× 150mm, wavelength 206nm, flow velocity 1ml/min, mobile phase:Acetonitrile:0.03M KH2PO4Buffer solution=45:55.
(3) fermentation results
Fermenting experiment result shows, with the increase step by step of copy number, PII (Pristinamycin IIA) yield also phase Should improve, SBJ1001, SBJ1002 and SBJ1003 are respectively 468,508 and 720mg/L, the relative bacterium (yield 323mg/L) that sets out 45%, 57% and 123% is respectively increased, such as Fig. 3.
Meanwhile, the inventors discovered that, engineering bacteria SBJ1000::AttB2 and SBJ1000::The PII yield of attB3 with set out Bacterium is not significantly different from.
The above results show that the further increase of the PII yield of engineering bacteria SBJ1002 and SBJ1003 is due to PII synthesis Caused by the increase of gene copy number is deleted rather than other gene clusters.
(4) genetic stability is determined
Meanwhile, engineering bacteria SBJ1003 has been carried out the continuous passage culture of 5 generations by the present inventor, fermentation results display offspring's PII yield is not significantly different from female generation, it was demonstrated that this multi-copy gene cluster based on site-specific recombination system integrates institute The engineering bacteria of structure is very stable in heredity, and homologous recombination is not susceptible between homologous genes cluster.
Embodiment 3, fermentation technology optimization further improves the PII yield of engineering bacteria
The present inventors have additionally discovered that, because pyostacin has stronger inhibition for itself synthesis with thalli growth, Addition macroporous absorbent resin can effectively alleviate this poisonous effect, further improve the biosynthesis of pyostacin.
Therefore, the present inventor with the addition of the macroporous absorbent resin HB60 of 6% (w/v) in SBJ1003 fermentation process, as a result It was found that, Pristinamycin IIAYield lifts 1.4 times again when being fermented without resin relatively, and with respect to starting strain SBJ1000 also improves 1.3 times under same culture conditions.It is excellent with the fermentation in later stage by gene cluster multicopy amplification method Change, most 4.4 times of PII output increaseds at last, from original 323mg/L be promoted to 1.75g/L, such as Fig. 4.
The all documents referred in the present invention are all incorporated as reference in this application, independent just as each document It is incorporated as with reference to such.In addition, it is to be understood that after above-mentioned instruction content of the invention has been read, those skilled in the art can Made various changes or modifications with to the present invention, these equivalent form of values equally fall within the model that the application appended claims are limited Enclose.

Claims (14)

1. a kind of method for making to be integrated into multicopy target gene or target gene cluster in streptomyces gene group, it is characterised in that Methods described includes:
(1) the attB sites of at least one external source are introduced in streptomyces gene group, acquisition carries the strepto- in external source attB sites Bacterium;
(2) method by engaging transfer, target gene or target gene cluster are incorporated into the streptomycete of step (1), are selected Target gene or target gene cluster are incorporated into the streptomycete in the endogenous attB sites of streptomyces gene group and external source attB sites, from And obtain the streptomycete for being integrated into multi-copy gene or gene cluster.
2. the method for claim 1, it is characterised in that the attB sites of described at least one external source are 1-2 external source AttB sites;The preferably 2 attB sites of external source.
3. method as claimed in claim 2, it is characterised in that the attB sites of 1-2 described external source are incorporated into streptomycete 1-2 following position is selected from genome:
I types polyketone biological synthesis gene cluster position in streptomyces gene group, and replace the biological conjunction of former I types polyketone of the position Into gene cluster;
Non-ribosomal peptides biological synthesis gene cluster position in streptomyces gene group, and replace the former non-ribosomal peptides of the position Biological synthesis gene cluster;Or
Type III polyketone biological synthesis gene cluster position in streptomyces gene group, and replace the former type III polyketone of the position to give birth to Thing synthetic gene cluster.
4. the method for claim 1, it is characterised in that described streptomycete includes:Rotation streptomycete, sky blue strepto- Bacterium, Streptomyces roseosporus or streptomyces hygroscopicus.
5. the method for claim 1, it is characterised in that described target gene or target gene cluster includes:It is original mould Plain component II synthetic gene clusters, pyostacin I synthetic gene clusters, Daptomycin synthetic gene cluster or rapamycin synthetic gene Cluster.
6. the method for claim 1, it is characterised in that in step (2), by engaging the method for transfer by target gene Or the method that target gene cluster is incorporated into the streptomycete of step (1) includes:By the plasmid of foreign gene-carrying or gene cluster with The mode for engaging transfer is imported into the streptomycete of step (1).
7. a kind of streptomyces gene engineering bacteria, it is characterised in that the genome of the genetic engineering bacterium includes at least one external source AttB sites, 1 endogenous endogenous attB site.
8. streptomyces gene engineering bacteria as claimed in claim 7, it is characterised in that attB of described at least one external source Point is the 1-2 attB site of external source;The preferably 2 attB sites of external source.
9. streptomyces gene engineering bacteria as claimed in claim 8, it is characterised in that the attB sites of 1-2 described external source It is incorporated into streptomyces gene group selected from 1-2 following position:
I types polyketone biological synthesis gene cluster position in streptomyces gene group, and replace the biological conjunction of former I types polyketone of the position Into gene cluster;
Non-ribosomal peptides biological synthesis gene cluster position in streptomyces gene group, and replace the former non-ribosomal peptides of the position Biological synthesis gene cluster;Or
Type III polyketone biological synthesis gene cluster position in streptomyces gene group, and replace the former type III polyketone of the position to give birth to Thing synthetic gene cluster.
10. the purposes of any described streptomyces gene engineering bacterias of claim 7-9, it is characterised in that carry many for preparing The streptomyces gene engineering bacteria of copy foreign gene or gene cluster.
The streptomyces gene engineering bacteria of multicopy target gene or target gene cluster, its feature are integrated with a kind of 11. genomes As many as it is that 3 target gene clusters of copy are included up in the genome of the genetic engineering bacterium, and in following position 3 positions:
Endogenous attB sites position in streptomyces gene group, and replace the original attB sites in the position;
I types polyketone biological synthesis gene cluster position in streptomyces gene group, and replace the biological conjunction of former I types polyketone of the position Into gene cluster;Or
Non-ribosomal peptides biological synthesis gene cluster position in streptomyces gene group, and replace the former non-ribosomal peptides of the position Biological synthesis gene cluster;Or
Type III polyketone biological synthesis gene cluster position in streptomyces gene group, and replace the former type III polyketone of the position to give birth to Thing synthetic gene cluster.
The streptomyces gene of multicopy target gene or target gene cluster is integrated with 12. genomes as claimed in claim 11 Engineering bacteria, it is characterised in that described target gene or target gene cluster includes:Pyostacin component II synthetic gene clusters, it is former Beginning mycin I synthetic gene cluster, Daptomycin synthetic gene cluster or rapamycin synthetic gene cluster etc..
The method of a kind of 13. utilization streptomycete high efficient expression target genes or target gene cluster, it is characterised in that described method Including:
A () prepares streptomycete in the method described in claim 1, make to be integrated into streptomyces gene group multicopy target gene or Target gene cluster;
B streptomycete that () incubation step (a) is obtained, so that high efficient expression target gene or target gene cluster.
14. methods as claimed in claim 13, it is characterised in that in step (b), add big also in the nutrient solution of streptomycete Macroporous adsorbent resin;It is preferred that adding 1-12% (w/v);The more preferably macroporous absorbent resin of 3-8%.
CN201510971596.4A 2015-12-22 2015-12-22 Multi-copy amplification method and application of streptomycete antibiotic biosynthesis gene cluster Active CN106906238B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510971596.4A CN106906238B (en) 2015-12-22 2015-12-22 Multi-copy amplification method and application of streptomycete antibiotic biosynthesis gene cluster

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510971596.4A CN106906238B (en) 2015-12-22 2015-12-22 Multi-copy amplification method and application of streptomycete antibiotic biosynthesis gene cluster

Publications (2)

Publication Number Publication Date
CN106906238A true CN106906238A (en) 2017-06-30
CN106906238B CN106906238B (en) 2020-08-14

Family

ID=59199730

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510971596.4A Active CN106906238B (en) 2015-12-22 2015-12-22 Multi-copy amplification method and application of streptomycete antibiotic biosynthesis gene cluster

Country Status (1)

Country Link
CN (1) CN106906238B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110951765A (en) * 2018-09-27 2020-04-03 中国科学院上海生命科学研究院 Multi-copy integration method for synthetic gene cluster of natural product of actinomycetes
CN111019873A (en) * 2018-10-09 2020-04-17 安徽吐露港生物科技有限公司 Method for rapidly integrating large-fragment DNA on genome of clostridium acetobutylicum
CN113249401A (en) * 2020-02-10 2021-08-13 中国科学院分子植物科学卓越创新中心 Method for improving streptomyces rapamycin yield

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1717489A (en) * 2002-11-28 2006-01-04 贝林格尔英格海姆法玛两合公司 Sequence specific DNA recombination in eukaryotic cells
CN101061214A (en) * 2004-10-22 2007-10-24 诺维信公司 Stable genomic integration of multiple polynucleotide copies

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1717489A (en) * 2002-11-28 2006-01-04 贝林格尔英格海姆法玛两合公司 Sequence specific DNA recombination in eukaryotic cells
CN101061214A (en) * 2004-10-22 2007-10-24 诺维信公司 Stable genomic integration of multiple polynucleotide copies

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
KENTARO HAGINAKA等: "Genetic approaches to generate hyper-producing strains of goadsporin: the relationships between productivity and gene duplication in secondary metabolite biosynthesis.", 《BIOSCIENCE, BIOTECHNOLOGY, AND BIOCHEMISTRY》 *
LEI LI等: "A stepwise increase in pristinamycin II biosynthesis by Streptomyces pristinaespiralis through combinatorial metabolic engineering", 《METABOLIC ENGINEERING》 *
LEI LI等: "Multiplexed site-specific genome engineering for overproducing bioactive secondary metabolites in actinomycetes", 《METABOLIC ENGINEERING》 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110951765A (en) * 2018-09-27 2020-04-03 中国科学院上海生命科学研究院 Multi-copy integration method for synthetic gene cluster of natural product of actinomycetes
CN110951765B (en) * 2018-09-27 2022-03-08 中国科学院分子植物科学卓越创新中心 Multi-copy integration method for synthetic gene cluster of natural product of actinomycetes
CN111019873A (en) * 2018-10-09 2020-04-17 安徽吐露港生物科技有限公司 Method for rapidly integrating large-fragment DNA on genome of clostridium acetobutylicum
CN113249401A (en) * 2020-02-10 2021-08-13 中国科学院分子植物科学卓越创新中心 Method for improving streptomyces rapamycin yield
CN113249401B (en) * 2020-02-10 2022-11-04 中国科学院分子植物科学卓越创新中心 Method for improving streptomyces rapamycin yield

Also Published As

Publication number Publication date
CN106906238B (en) 2020-08-14

Similar Documents

Publication Publication Date Title
CN106190921B (en) A kind of corynebacterium glutamicum and application
US20210153507A1 (en) A Strain Of Bactericidal Nitrogen-Fixing Pseudomonas Protegens, A Fermentation Method And An Application Thereof
CN102191208A (en) Gene engineering bacteria capable of highly producing pleocidin and preparation method thereof
CN105543156A (en) Recombinant strain and preparation method and application thereof
Yu et al. Genome shuffling of Streptomyces roseosporus for improving daptomycin production
CN106906238A (en) A kind of streptomycete antibiotic biological synthesis gene cluster multicopy amplification method and application
CN106399114B (en) A kind of method and application improving DNC wireless ethanol tolerance ability
CN110029069A (en) The palpus saccharopolyspora strain engineered strain and its application that one plant of flaviolin gene cluster knocks out
CN106635945A (en) Recombinant strain and preparation method thereof and method for producing L-threonine
CN102703495A (en) Method for improving yield of streptomycete antibiotic and plasmid thereof
CN105255936A (en) Method for establishing salinispora arenlocola CNS-205 gene genetic manipulation system
WO2020134427A1 (en) Use of sll0528 gene in improving ethanol tolerance of synechocystis sp. pcc 6803
CN100460511C (en) Method for inducing and cultivating hairy root system of Saussurea medusa
CN102660488A (en) Genetic engineering bacterium capable of promoting biological synthesis of medermycin and application thereof
CN102373171B (en) Nucleoside antibiotic A201A superior strain and construction method thereof
CN102719388A (en) Method for improving yield of streptomyces antibiotics and plasmids thereof
CN105176904A (en) Genetic engineering strain Streptomyces tsukubaensis L21 and application thereof
CN116121160A (en) Genetically engineered bacterium for over-expressing pyrB gene and method for producing L-arginine by using genetically engineered bacterium
CN106086055B (en) The strain of DNC wireless algae and its construction method that a kind of pair of alcohol resistance significantly improves
CN101475944B (en) Promoter replacement method for improving Bacillus amyloliquefaciens yield
CN108220216A (en) A kind of nitrogen-fixing microorganism of resistance to ammonium for being overexpressed glnR genes and its construction method and application
CN113881615A (en) Xenorhabdus nematophila with high yield of Xcn1 and application thereof
CN109554321B (en) Genetically engineered bacterium for high-yield lipopeptide and application thereof
CN101434931B (en) Streptomyces clavuligerus, as well as preparation method and application thereof
CN107699532B (en) 3, 7-dihydroxy tropolone high-yield strain and fermentation culture method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right
TA01 Transfer of patent application right

Effective date of registration: 20200603

Address after: 200032 building 4, No. 300 Fenglin Road, Xuhui District, Shanghai

Applicant after: Center for excellence and innovation in molecular plant science, Chinese Academy of Sciences

Applicant after: Shanghai Health Creation Center for Biopharmaceutical R&D Co.,Ltd.

Address before: 200031, 319 Yueyang Road, Shanghai, Shanghai, Xuhui District

Applicant before: SHANGHAI INSTITUTES FOR BIOLOGICAL SCIENCES, CHINESE ACADEMY OF SCIENCES

Applicant before: Shanghai Health Creation Center for Biopharmaceutical R&D Co.,Ltd.

GR01 Patent grant
GR01 Patent grant